Health In Tech, Inc. Financials
This page shows Health In Tech, Inc. (HIT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025 growth was driven by higher-volume, lower-gross-margin business, while cash generation and liquidity still held up.
From FY2024 to FY2025, revenue rose to$33.3M as gross margin fell to62.8% . Operating cash flow still reached$3.1M , above net income of$1.3M , while receivables shrank, suggesting the added 2025 volume was less profitable at the gross level but converted to cash faster and absorbed overhead better.
The balance sheet looked more self-funding in FY2025: cash remained near
This is not a story of steadily richer economics per dollar sold: net margin was
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Health In Tech, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Health In Tech, Inc.'s revenue surged 71.0% year-over-year to $33.3M, reflecting rapid business expansion. This strong growth earns a score of 87/100.
Health In Tech, Inc. carries a low D/E ratio of 0.35, meaning only $0.35 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 95/100, indicating a strong balance sheet with room for future borrowing.
Health In Tech, Inc.'s current ratio of 3.13 indicates adequate short-term liquidity, earning a score of 60/100. The company can meet its near-term obligations, though with limited headroom.
Health In Tech, Inc.'s ROE of 7.5% shows moderate profitability relative to equity, earning a score of 52/100. This is up from 5.1% the prior year.
Health In Tech, Inc. passes 5 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Health In Tech, Inc. generates $2.45 in operating cash flow ($3.1M OCF vs $1.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Health In Tech, Inc. generated $33.3M in revenue in fiscal year 2025. This represents an increase of 71.0% from the prior year.
Health In Tech, Inc. reported $1.3M in net income in fiscal year 2025. This represents an increase of 90.7% from the prior year.
Health In Tech, Inc. earned $0.02 per diluted share (EPS) in fiscal year 2025. This represents an increase of 100.0% from the prior year.
Cash & Balance Sheet
Health In Tech, Inc. held $7.7M in cash against $0 in long-term debt as of fiscal year 2025.
Margins & Returns
Health In Tech, Inc.'s gross margin was 62.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 16.4 percentage points from the prior year.
Health In Tech, Inc.'s net profit margin was 3.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.4 percentage points from the prior year.
Health In Tech, Inc.'s ROE was 7.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2.4 percentage points from the prior year.
Capital Allocation
Health In Tech, Inc. invested $1.6M in research and development in fiscal year 2025. This represents a decrease of 44.2% from the prior year.
HIT Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.5M-11.6% | $8.5M-8.8% | $9.3M+16.2% | $8.0M+63.4% | $4.9M+10.0% | $4.5M-10.9% | $5.0M-2.4% | $5.1M |
| Cost of Revenue | $3.4M+1.0% | $3.3M+11.4% | $3.0M+12.9% | $2.7M+140.2% | $1.1M+13.0% | $980K+0.5% | $975K-1.5% | $990K |
| Gross Profit | $4.1M-19.7% | $5.1M-18.5% | $6.3M+17.8% | $5.4M+41.0% | $3.8M+9.1% | $3.5M-13.6% | $4.0M-2.6% | $4.1M |
| R&D Expenses | $213K-9.6% | $236K-59.5% | $583K+8.3% | $538K-15.1% | $634K-11.8% | $718K+2.4% | $702K-7.7% | $760K |
| SG&A Expenses | $3.2M-7.9% | $3.5M-8.6% | $3.8M+16.3% | $3.2M+14.0% | $2.8M+57.0% | $1.8M-0.2% | $1.8M-9.1% | $2.0M |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | $0-100.0% | $165K0.0% | $165K0.0% | $165K |
| Income Tax | -$141K-195.4% | $148K-26.9% | $203K+9.0% | $186K+456.3% | $33K+9.0% | $31K-51.6% | $63K-30.6% | $91K |
| Net Income | -$303K-166.9% | $452K-28.3% | $631K+26.5% | $499K+445.9% | -$144K-138.3% | $376K+11.3% | $338K+236.2% | $101K |
| EPS (Diluted) | N/A | $0.010.0% | $0.010.0% | $0.01 | N/A | $0.010.0% | $0.01 | N/A |
HIT Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $23.1M+1.5% | $22.8M+2.6% | $22.2M+4.0% | $21.3M+35.3% | $15.8M | N/A | N/A | N/A |
| Current Assets | $16.2M+7.4% | $15.0M+1.3% | $14.9M-4.6% | $15.6M+44.4% | $10.8M | N/A | N/A | N/A |
| Cash & Equivalents | $7.7M-4.4% | $8.0M-1.4% | $8.1M+7.4% | $7.6M-3.5% | $7.8M+349.2% | $1.7M-19.2% | $2.2M+59.1% | $1.4M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $756K-12.9% | $869K-32.2% | $1.3M-39.3% | $2.1M+28.1% | $1.6M | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $6.0M+6.8% | $5.6M-2.7% | $5.8M-19.7% | $7.2M+175.8% | $2.6M | N/A | N/A | N/A |
| Current Liabilities | $5.2M-1.6% | $5.2M-2.8% | $5.4M-20.2% | $6.8M+216.9% | $2.1M | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $17.1M-0.3% | $17.2M+4.5% | $16.4M+16.0% | $14.2M+7.5% | $13.2M+90.6% | $6.9M+5.8% | $6.5M+5.5% | $6.2M |
| Retained Earnings | $5.2M-5.5% | $5.5M+8.9% | $5.1M+14.2% | $4.4M+12.7% | $3.9M | N/A | N/A | N/A |
HIT Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $451K-33.1% | $674K-54.5% | $1.5M+180.9% | $527K+199.3% | -$531K-125.0% | $2.1M+67.5% | $1.3M+286.2% | -$680K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$768K-3.1% | -$745K+18.1% | -$910K-29.3% | -$703K-29.8% | -$542K-705.8% | -$67K+28.4% | -$94K+29.6% | -$133K |
| Financing Cash Flow | -$37K+14.5% | -$44K-429.5% | -$8K+91.6% | -$98K-101.4% | $7.2M+390.5% | -$2.5M-569.5% | -$369K-51.7% | -$243K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
HIT Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 55.0%-5.6pp | 60.6%-7.2pp | 67.8%+0.9pp | 66.8%-10.6pp | 77.4%-0.6pp | 78.0%-2.5pp | 80.5%-0.2pp | 80.7% |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | -4.0%-9.4pp | 5.3%-1.4pp | 6.8%+0.5pp | 6.2%+9.2pp | -2.9%-11.4pp | 8.4%+1.7pp | 6.8%+4.8pp | 2.0% |
| Return on Equity | -1.8%-4.4pp | 2.6%-1.2pp | 3.8%+0.3pp | 3.5%+4.6pp | -1.1%-6.5pp | 5.4%+0.3pp | 5.2%+3.6pp | 1.6% |
| Return on Assets | -1.3%-3.3pp | 2.0%-0.9pp | 2.8%+0.5pp | 2.3%+3.3pp | -0.9% | N/A | N/A | N/A |
| Current Ratio | 3.13+0.3 | 2.87+0.1 | 2.76+0.5 | 2.31-2.8 | 5.06 | N/A | N/A | N/A |
| Debt-to-Equity | 0.35+0.0 | 0.33-0.0 | 0.35-0.2 | 0.51+0.3 | 0.20 | N/A | N/A | N/A |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is Health In Tech, Inc.'s annual revenue?
Health In Tech, Inc. (HIT) reported $33.3M in total revenue for fiscal year 2025. This represents a 71.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Health In Tech, Inc.'s revenue growing?
Health In Tech, Inc. (HIT) revenue grew by 71% year-over-year, from $19.5M to $33.3M in fiscal year 2025.
Is Health In Tech, Inc. profitable?
Yes, Health In Tech, Inc. (HIT) reported a net income of $1.3M in fiscal year 2025, with a net profit margin of 3.8%.
What is Health In Tech, Inc.'s gross margin?
Health In Tech, Inc. (HIT) had a gross margin of 62.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Health In Tech, Inc.'s net profit margin?
Health In Tech, Inc. (HIT) had a net profit margin of 3.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Health In Tech, Inc.'s return on equity (ROE)?
Health In Tech, Inc. (HIT) has a return on equity of 7.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Health In Tech, Inc.'s operating cash flow?
Health In Tech, Inc. (HIT) generated $3.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Health In Tech, Inc.'s total assets?
Health In Tech, Inc. (HIT) had $23.1M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Health In Tech, Inc. spend on research and development?
Health In Tech, Inc. (HIT) invested $1.6M in research and development during fiscal year 2025.
What is Health In Tech, Inc.'s current ratio?
Health In Tech, Inc. (HIT) had a current ratio of 3.13 as of fiscal year 2025, which is generally considered healthy.
What is Health In Tech, Inc.'s debt-to-equity ratio?
Health In Tech, Inc. (HIT) had a debt-to-equity ratio of 0.35 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Health In Tech, Inc.'s return on assets (ROA)?
Health In Tech, Inc. (HIT) had a return on assets of 5.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Health In Tech, Inc.'s Piotroski F-Score?
Health In Tech, Inc. (HIT) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Health In Tech, Inc.'s earnings high quality?
Health In Tech, Inc. (HIT) has an earnings quality ratio of 2.45x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Health In Tech, Inc.?
Health In Tech, Inc. (HIT) scores 49 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.